2026 Cellular Therapy Conference, Charlotte
Accreditation: 5.17 Nursing Contact Hours | 5.17 ABIM MOC II | 5.17 AMA PRA Category 1 Credit™ | 5.17 ACPE Pharmacy
Venue: Le Méridien Charlotte, 555 South McDowell Street, Charlotte, NC, United States
Official conference page for 2026 Cellular Therapy Conference, Charlotte. https://binaytara.org/projects/conferences/cellular-therapy-conference-charlotte
About 2026 Cellular Therapy Conference, Charlotte
Faculty and committee
Our Speakers
Faculty
Conference program and agenda
Our Agenda
Friday, July 24th, 2026
All timings are in Eastern Time (EDT, GMT-04:00) time.
Session Chair: Earle Burgess
08:20 AM - 08:40 AM
Tumor-Infiltrating Lymphocyte (TIL) Therapy and Lifileucel in Advanced Melanoma: From Trials to Clinical Practice – Theresa Medina, MD
08:40 AM - 09:00 AM
The Emerging Role of BiTE Therapy in the Management of SCLC – Daniel Carrizosa
09:00 AM - 09:20 AM
Advancing Immunotherapy in Prostate Cancer: The Emerging Role of Cellular and Bispecific Therapies – Earle Burgess
Session Chair: Peter Voorhees
09:30 AM - 09:40 AM
Topic TBD
09:40 AM - 10:00 AM
Topic TBD
10:00 AM - 10:10 AM
Topic TBD
10:10 AM - 10:30 AM
Topic TBD
Session Chair: Thomas "Greg" Knight
10:30 AM - 10:50 AM
CAR-T and Bispecifics for CLL – Debbie Stephens, DO
10:50 AM - 11:10 AM
CAR-T and Bispecifics for ALL
11:10 AM - 11:30 AM
Maintenance After Transplant in Leukemia
11:30 AM - 11:50 AM
Transplantation and Cellular Therapy in MPNs
11:50 AM - 12:05 PM
Panel Discussion
Session Chair: Stefanie Sarantopoulos
01:05 PM - 01:25 PM
The Cord Blood Donor Option: Is it Really Only a Donor of Last Resort?
01:25 PM - 01:45 PM
Cyclophosphamide: A Major Advance, Data-Driven Considerations For Use
01:45 PM - 02:05 PM
FDA Approved Agents for GVHD
02:05 PM - 02:25 PM
The Nuts and Bolts of Chronic GVHD Care and Long Term Care of Allo Act Patients – Stefanie Sarantopoulos
02:25 PM - 02:40 PM
Panel Discussion
Moderators:
Stefanie Sarantopoulos
02:40 PM - 02:50 PM
Bispecifics for DLBCL – Mary Beth Seegars
02:50 PM - 03:00 PM
CAR-T for DLBCL – Chenyu Lin, MD
03:00 PM - 03:10 PM
CAR-T and Bispecifics for Indolent Lymphomas – Alan Skarbnik, MD
03:10 PM - 03:20 PM
CAR-T for Mantle Cell Lymphoma – Nilanjan Ghosh, MD
03:20 PM - 03:40 PM
Panel Discussion